{"id":446465,"date":"2021-02-27T09:03:27","date_gmt":"2021-02-27T14:03:27","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=446465"},"modified":"2021-02-27T09:03:27","modified_gmt":"2021-02-27T14:03:27","slug":"vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/","title":{"rendered":"VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline \u2013 VYGR"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, Feb.  27, 2021  (GLOBE NEWSWIRE) &#8212; <strong>WHY: <\/strong>Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Voyager Therapeutics, Inc. (NASDAQ: VYGR) between June 1, 2017 and November 9, 2020, inclusive (the \u201cClass Period\u201d), of the important <strong>March 24, 2021 lead plaintiff deadline.<\/strong><\/p>\n<p align=\"justify\">\n        <strong>SO WHAT:<\/strong> If you purchased Voyager securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p align=\"justify\">\n        <strong>WHAT TO DO NEXT: <\/strong>To join the Voyager class action, go to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HMfu6ktl0TNlyKDVnaDEf4RQR0hLIZwBQ_l9tGtV2Y7h8-OJ-ILj4-I6xaqaSTTC5wx3rDubJ-H4k0pc6CXTptNDQkdJ5MCU0hCZk4U_lGqhPc6DQ2fZcSRGGjB3tcnu0RSKkRQups9dGSw9p6WiHIiJqF5MnVaCbM7-dI1o4Bw=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/www.rosenlegal.com\/cases-register-2026.html<\/a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5PDdBVn_b3Ywz6AQnbhQlOo3ryRpW1LZPXmKvpB2DWadrEyLY6W4A6CvL3Okz6FYxSFnGjrZS0ARcgOQxQ15ichMWttnyV3fFf4qNz87DxY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">pkim@rosenlegal.com<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OEot-PKnlCyRuPirJgYoiQAfmAxNsAGF5LQ39TYhQ_o3WUGWOuqKaOQXK5235IkJyGYNqNvDT5sE9kDuQE42FQCpUiB_3v_mSeyHu2VKU0A=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">cases@rosenlegal.com<\/a> for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court <strong>no later than March 24, 2021<\/strong>. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.<\/p>\n<p align=\"justify\">\n        <strong>WHY ROSEN LAW: <\/strong>We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs\u2019 Bar. Many of the firm\u2019s attorneys have been recognized by Lawdragon and Super Lawyers.<\/p>\n<p align=\"justify\">\n        <strong>DETAILS OF THE CASE: <\/strong>According to the lawsuit, throughout the Class Period, defendants made false and\/or misleading statements and\/or failed to disclose that: (1) Voyager\u2019s VY-HTT01 IND submission to the FDA lacked key information regarding certain chemistry, manufacturing and controls matters, including, <em>inter alia<\/em>, drug-device compatibility and drug substance and product characterization; (2) Voyager\u2019s investigational new drug (\u201cIND\u201d) submission for VY-HTT01 was therefore deficient; (3) Voyager had thus materially overstated the likelihood of FDA approval for VY-HTT01 based on the IND submission; and (4) as a result, Voyager\u2019s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.<\/p>\n<p align=\"justify\">To join the Voyager class action, go to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HMfu6ktl0TNlyKDVnaDEf4RQR0hLIZwBQ_l9tGtV2Y7h8-OJ-ILj4-I6xaqaSTTC1WLZ9NhSY9GIN-C30g8__54Ap8i1ShCeGM2jFol0G655NeGderM0cb9bPX1KZkOziYxBAn_3PDqXzP9fQMU4gwSBQrjj7pwB049hpDU8lS4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/www.rosenlegal.com\/cases-register-2026.html<\/a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5PDdBVn_b3Ywz6AQnbhQlAFkhGbLN-0peoa_2EYnJMHKP_-8p-hZ3BYr7DCemc-t7aAqFh1kcLBpfJ12waAVixg7pcQFUgM8nqYixhaykIE=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">pkim@rosenlegal.com<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OEot-PKnlCyRuPirJgYoiY6kgdHVXpLKVn78NFY0ITjjdJSe0iEgf8ceUF0UcsfddIM12SGEYoFcLdKwzeUaoia78E1J4x7ekUoMMgLWMt8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">cases@rosenlegal.com<\/a> for information on the class action.<\/p>\n<p align=\"justify\">No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor\u2019s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.<\/p>\n<p align=\"justify\">Follow us for updates on LinkedIn: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=z85htvJI4n6JWcXNrLl0N6GR45rKCVpRdJ87oB5GJGGOa98W5gas8Sw-HGT3_J-oucCGMSthz6kRTwCsM9JBfRt1DHFuQGap_lfpFhrQOAqNBXy_c22BzI-KVrxtkXDIQWCX3OehER1M-SjOjmo8nUNDW6JQA61095El1C8ny_c=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.linkedin.com\/company\/the-rosen-law-firm<\/a> or on Twitter: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=z85htvJI4n6JWcXNrLl0N5VJSRQG3RAij87pNxOp9Tjz0ndUmz4IBJ5s7TN4GqGiZPhUGC1RcPc-TOtSZZYmBm5hvCO71188G59N6TsT1bUQX3aT-26Zwou_g9Ov-E4K\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/twitter.com\/rosen_firm<\/a> or on Facebook: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=z85htvJI4n6JWcXNrLl0N7v3VK4OKAOXWVixRCx5AsVGihVJp4NUCJU-wN6wUoc4ASQEfNm-wHDsf2ZjUfvQsebGsOTy70kFIZ3mhudfFQtL9FW9qPjVdkUPc4puqkLa\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.facebook.com\/rosenlawfirm<\/a>.<\/p>\n<p align=\"justify\">Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n<p align=\"justify\">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>Contact Information:<\/p>\n<p>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Laurence Rosen, Esq.<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Phillip Kim, Esq.<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0The Rosen Law Firm, P.A.<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0275 Madison Avenue, 40<sup>th<\/sup> Floor<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0New York, NY 10016<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Tel: (212) 686-1060<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Toll Free: (866) 767-3653<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fax: (212) 202-3827<br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=87-daUqORzKXRngv2QX7-y7YnKBp9mkyJiSWMczwRsyI_D6cJNWXmalBL4iraIe20iPTf8zfjp-KYkb0pElGESNEObeT9YlUw6OAXEDnos8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">lrosen@rosenlegal.com<\/a><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5PDdBVn_b3Ywz6AQnbhQlJPQypP-v-Fyn1dtu5W4kPEq9PtaoKeoDJAkbPwSSOYNW9T2qPAjzkLOqBimXZlfjMbFKm28nHqbtUYjIpERqso=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">pkim@rosenlegal.com<\/a><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OEot-PKnlCyRuPirJgYoiYl_5Sxe-S8jhembR59p1sJTlQJ-oBnrZBe1u11ygMRiLfjzGLh7-6Nt6h4vFvMykXNrH7KeZZE4XH6Z1CF-gqU=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">cases@rosenlegal.com<\/a><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nrusrAJMD2SxKXVRdYqSNSShQBN1DR4ia2bdxckib6DKgB1WodQg7Eakgpy_lPdUupGHvyqzW-7-9oq4vANX-Gg5c5u7L9AzwgbSpJFwqBo=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.rosenlegal.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE2MTA1MiMzOTk5MDc4IzIwMjA0MTE=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/e6898ed5-62e9-4400-b736-103b345adbef\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Feb. 27, 2021 (GLOBE NEWSWIRE) &#8212; WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Voyager Therapeutics, Inc. (NASDAQ: VYGR) between June 1, 2017 and November 9, 2020, inclusive (the \u201cClass Period\u201d), of the important March 24, 2021 lead plaintiff deadline. SO WHAT: If you purchased Voyager securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 WHAT TO DO NEXT: To join the Voyager class action, go to http:\/\/www.rosenlegal.com\/cases-register-2026.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline \u2013 VYGR&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-446465","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline \u2013 VYGR - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline \u2013 VYGR - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Feb. 27, 2021 (GLOBE NEWSWIRE) &#8212; WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Voyager Therapeutics, Inc. (NASDAQ: VYGR) between June 1, 2017 and November 9, 2020, inclusive (the \u201cClass Period\u201d), of the important March 24, 2021 lead plaintiff deadline. SO WHAT: If you purchased Voyager securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 WHAT TO DO NEXT: To join the Voyager class action, go to http:\/\/www.rosenlegal.com\/cases-register-2026.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already &hellip; Continue reading &quot;VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline \u2013 VYGR&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-27T14:03:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE2MTA1MiMzOTk5MDc4IzIwMjA0MTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline \u2013 VYGR\",\"datePublished\":\"2021-02-27T14:03:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\\\/\"},\"wordCount\":616,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE2MTA1MiMzOTk5MDc4IzIwMjA0MTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\\\/\",\"name\":\"VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline \u2013 VYGR - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE2MTA1MiMzOTk5MDc4IzIwMjA0MTE=\",\"datePublished\":\"2021-02-27T14:03:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE2MTA1MiMzOTk5MDc4IzIwMjA0MTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE2MTA1MiMzOTk5MDc4IzIwMjA0MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline \u2013 VYGR\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline \u2013 VYGR - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/","og_locale":"en_US","og_type":"article","og_title":"VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline \u2013 VYGR - Market Newsdesk","og_description":"NEW YORK, Feb. 27, 2021 (GLOBE NEWSWIRE) &#8212; WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Voyager Therapeutics, Inc. (NASDAQ: VYGR) between June 1, 2017 and November 9, 2020, inclusive (the \u201cClass Period\u201d), of the important March 24, 2021 lead plaintiff deadline. SO WHAT: If you purchased Voyager securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 WHAT TO DO NEXT: To join the Voyager class action, go to http:\/\/www.rosenlegal.com\/cases-register-2026.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already &hellip; Continue reading \"VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline \u2013 VYGR\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-27T14:03:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE2MTA1MiMzOTk5MDc4IzIwMjA0MTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline \u2013 VYGR","datePublished":"2021-02-27T14:03:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/"},"wordCount":616,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE2MTA1MiMzOTk5MDc4IzIwMjA0MTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/","name":"VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline \u2013 VYGR - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE2MTA1MiMzOTk5MDc4IzIwMjA0MTE=","datePublished":"2021-02-27T14:03:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE2MTA1MiMzOTk5MDc4IzIwMjA0MTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE2MTA1MiMzOTk5MDc4IzIwMjA0MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-investor-notice-rosen-a-leading-law-firm-encourages-voyager-therapeutics-inc-investors-to-secure-counsel-before-important-march-24-deadline-vygr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"VYGR INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors to Secure Counsel Before Important March 24 Deadline \u2013 VYGR"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/446465","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=446465"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/446465\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=446465"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=446465"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=446465"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}